Disc Medicine, Inc. (IRON)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$79.23-0.18%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · IRON
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Operating Expenses & Income | |||||||
| Selling, General & Admin | 79.9 | 65.4 | 33.0 | 21.9 | — | — | — |
| R&D Expenses | 189.4 | 170.6 | 96.7 | 69.3 | 33.4 | 25.2 | 28.2 |
| Operating Income | (269.3) | (236.0) | (129.7) | (91.1) | (47.5) | (30.9) | (34.0) |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | 3.6 | 0.6 | — | — | 2.2 | 6.8 |
| Other Non-Operating Income / Expenses | 23.7 | 24.2 | 20.7 | 14.8 | 0.6 | (5.0) | — |
| Asset Writedown | — | — | — | 0.0 | 0.0 | 0.0 | — |
| EBT, Incl. Unusual Items | (245.6) | (211.8) | (109.0) | (76.3) | (46.8) | — | — |
| Income Tax Expense | 0.3 | 0.4 | 0.4 | 0.1 | 0.0 | — | — |
| Net Income | |||||||
| Net Income | (245.9) | (212.2) | (109.4) | (76.4) | (46.8) | (36.0) | (40.8) |
| Per Share | |||||||
| Basic EPS | (6.36) | (6.01) | (3.96) | (3.42) | (45.05) | (40.95) | — |
| Diluted EPS | (6.36) | (6.01) | (3.96) | (3.42) | (45.05) | (40.95) | — |
| Basic Weighted Avg Shares | 38.7 | 35.3 | 27.6 | 22.3 | 1.0 | 0.9 | — |
| Diluted Weighted Avg Shares | 38.7 | 35.3 | 27.6 | 22.3 | 1.0 | 0.9 | — |
| Supplemental | |||||||
| EBITDA | — | (235.7) | (129.6) | (91.0) | (47.4) | (30.9) | — |
| EBIT | (269.3) | (236.0) | (129.7) | (91.1) | (47.5) | (30.9) | (34.0) |
| Effective Tax Rate | -0.1% | — | — | -0.1% | 0.0% | — | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.